Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Lab Stakeholders Take Action to Prevent Drastic Cuts in the Medicare Lab Fee Schedule

Letter from Congress to CMS asks for delay in reporting rule of Protecting Access to Medicare Act of 2014

WITH MANY CLINICAL LABORATORY STAKEHOLDERS anticipating major revenue shortfalls due to the Protecting Access to Medicare Act lab test market price reporting rule that went into effect January 1, THE DARK REPORT reports overlooked news that, at the behest of clinical laboratory associations, elected officials in Congress have signed a letter that asks the Centers for Medicare & Medicaid Services to …

Lab Stakeholders Take Action to Prevent Drastic Cuts in the Medicare Lab Fee Schedule Read More »

To access this post, you must purchase The Dark Report.

Comments

;